Novo Nordisk A/SNVO

Is NVO cheap right now? Every multiple below is scored against its own 10-year range, not a sector average.

$39.14+0.85 (+2.22%)24:00 UTC
NYSEHealthcare

Company snapshot

Market Cap
$174B
Large-cap
+84%
2016 — today
10-Year Price
+110%
2016 — today
52-Week Range
$35.29$63.98
Current $39.14· 13%

Novo Nordisk (est. 1923, Bagsvaerd, Denmark) researches, manufactures, and distributes pharmaceuticals across Europe, the Middle East, Africa, Asia, and North America. Operations span two units: Diabetes and Obesity Care—covering diabetes, obesity, and cardiovascular therapies—and Rare Disease, focusing on blood disorders, endocrine conditions, and hormone replacement. Beyond drugs, it produces insulin/growth hormone pens and digital diabetes management tools. It maintains strategic partnerships, including collaborations with UNICEF and Valo Health.

Similar companies

Healthcare companies of comparable size — each one shown against its own 10-year range, not a sector average. Browse all stocks we cover.

Valuation in context

P/E ratio
10.0
Near historic low
Near historic low — last 10 years
Sector median 25.4below sector
P/B ratio
5.2
Near historic low
Near historic low — last 10 years
Sector median 2.2above sector
EV / EBITDA
6.9
Near historic low
Near historic low — last 10 years
Sector median 15.7below sector
Dividend Yield
4.6%
Near historic high
Near historic highs — last 10 years
Sector median 1.8%above sector
PEG ratio
0.5
Near historic low
Near historic low — last 10 years
Sector median 1.8below sector
FCF Yield
4.2%
Above average
Above the 10-year average
Sector median -12.6%above sector
Free · No credit card needed

Get alerted when NVO is cheap

Set a free alert — we'll push you when P/E, yield, or other metrics cross a historical threshold.